Study details
Enrolling now
Proof of Concept Trial to Evaluate MetriDx Test for Endometriosis
Hera Biotech, Inc.
NCT IDNCT05698212ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
75
Study length
about 7 months
Ages
18–50
Sex
Female only
Locations
3 sites in MI, TX
What this study is about
This trial is testing a new test, called MetriDx, that can help diagnose endometriosis. The test involves taking a sample from the uterus and analyzing it with AI technology. The goal is to see if this test can accurately identify biomarkers associated with endometriosis without needing surgery.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.MetriDx
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Reproductive Health